Isolation and characterization of a large soluble form of fibronectin that stimulates adhesion, spreading, and alignment of mouse erythroleukemia cells

Experimental Cell Research

Volumn 316, Issue 15, 2010, Pages 2402-2413

  Scher, Barbara M ^a   Mistry, Sucharita J ^a   Haque, Nasreen S ^b   Scher, William ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK CITY COLLEGE OF TECHNOLOGY   (United States)

Author keywords

Cell adhesion factor; Erythroid; Erythroleukemia; Fibronectin; MEL cells

Indexed keywords

FIBRONECTIN; POLYSTYRENE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL ADHESION; CELL ELONGATION; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ISOLATION; PROTEIN PURIFICATION; SMOOTH MUSCLE;

EID: 77955051105     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.05.034     Document Type: Article

References (53)

1. Ruoslahti E. Versatile mechanisms of cell adhesion. The Harvey Lecture Series 84 1990, 1-17. Wiley-Liss, Inc, New York.
2. Elangbam C.S., Dahlgren R.R. Cell adhesion molecules-update. Vet. Pathol. 1997, 34:61-73.
3. Stupack D.G. The biology of integrins. Oncology 2007, 21:6-12.
4. Hynes R.O. Fibronectins 1990, Springer-Verlag, New York. A. Rich (Ed.).
5. Young T.H., Tu H.R., Chan C.C., Huang Y.C., Yen M.H., Cheng N.C., Chiu H.C., Lin S.J. The enhancement of dermal papilla cell aggregation by extracellular matrix proteins through effects on cell-substratum adhesivity and cell motility. Biomaterials 2009, 30:5031-5040.
6. Pankov R., Yamada K.M. Fibronectin at a glance. J. Cell Sci. 2002, 115:3861-3863.
7. R. A. Proctor, Fibronectin: a brief overview of its structure, function, and physiology, 9 Suppl 4 (1987) S317-21.
8. Friend C., Scher W., Holland J.G., Sato T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Natl. Acad. Sci. USA 1971, 68:378C-382C.
9. Waxman S., Scher W., Scher B.M. Basic principles for utilizing combination differentiation agents. Cancer Detect. Prev. 1986, 9:395-407.
10. Demsey A., Grimley P.M. Characteristics of a surface-adherent subline derived from Friend erythroleukemia cells in continuous suspension culture. Cancer Res. 1976, 36:384-393.
11. Benedetto A., Amici C., Djaczenko W., Zaniratti S., Santoro M.G. Role of fibronectin in the adhesion of Friend erythroleukemia cells. Exp. Cell Res. 1981, 134:219-229.
12. Deisseroth A., Hendrick D. Human alpha-globin gene expression following chromosomal dependent gene transfer into mouse erythroleukemia cells. Cell 1978, 15:55-63.
13. Baron M.H., Maniatis T. Rapid reprogramming of globin gene expression in transient heterokaryons. Cell 1986, 46:591-602.
14. Bieker J.J., Southwood C.M. The erythroid Kruppel-like factor transactivation domain is a critical component for cell-specific inducibility of a beta-globin promoter. Mol. Cell. Biol. 1995, 15:852-860.
15. Ren S., Li J., Atweh G.F. CACCC and GATA-1 sequences make the constitutively expressed alpha-globin gene erythroid-responsive in mouse erythroleukemia cells. Nucleic Acids Res. 1996, 24:342-347.
16. Marks P.A., Michaeli J., Jackson J., Richon V.M., Rifkind R.A. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC. Prog. Clin. Biol. Res. 1989, 316B:171-181.
17. Chao M.V., Mellon P., Charnay P., Maniatis T., Axel R. The regulated expression of beta-globin genes introduced into mouse erythroleukemia cells. Cell 1983, 32:483-493.
18. Hug B.A., Moon A.M., Ley T.J. Structure and function of the murine beta-globin locus control region 5' HS-3. Nucleic Acids Res. 1992, 20:5771-5778.
19. Friend C. Immunological studies on the leukemia agent of Swiss mice. Acta Unio. Int. Contra Cancrum 1960, 16:1171-1174.
20. Kouhara H., Koga M., Kasayama S., Tanaka A., Kishimoto T., Sato B. Transforming activity of a newly cloned androgen-induced growth factor. Oncogene 1994, 9:455-462.
21. Mistry S.J., Bank A., Atweh G.F. Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure. Mol. Cancer Res. 2007, 5:773-782.
22. Katayama Y., Frenette P.S. Galactocerebrosides are required postnatally for stromal-dependent bone marrow lymphopoiesi. Immunity 2003, 18:789-800.
23. Haque N.S., Fallon J.T., Taubman M.B., Harpel P.C. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Blood 2001, 97:39-45.
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
25. Josse D., Ebel C., Stroebel D., Fontaine A., Borges F., Echalier A., Baud D., Renault F., Le Maire M., Chabrieres E., Masson P. Oligomeric states of the detergent-solubilized human serum paraoxonase (PON1). J. Biol. Chem. 2002, 277:33386-33397.
26. Davis B.J. Disc electrophoresis. II. Method and application to human serum proteins. Ann. NY Acad. Sci. 1964, 121:404-427.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
28. Patel V.P., Lodish H.F. Loss of adhesion of murine erythroleukemia cells to fibronectin during erythroid differentiation. Science 1984, 224:996-998.
29. Patel V.P., Lodish H.F. A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes. J. Cell Biol. 1987, 105:3105-3118.
30. Giancotti F.G., Comoglio P.M., Tarone G. Fibronectin-plasma membrane interaction in the adhesion of hemopoietic cells. J. Cell Biol. 1986, 103:429-437.
31. Bazzoni G., Shih D.T., Buck C.A., Hemler M.E. Monoclonal antibody 9EG7 defines a novel beta 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium. J. Biol. Chem. 1995, 270:25570-25577.
32. Hayman E.G., Ruoslahti E. Distribution of fetal bovine serum fibronectin and endogenous rat cell fibronectin in extracellular matrix. J. Cell Biol. 1979, 83:255-259.
33. Mira-y-Lopez R., Joseph-Silverstein J., Rifkin D.B., Ossowski L. Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells. Proc. Natl. Acad. Sci. USA 1986, 83:7780-7784.
34. Xiong S., Zhang L., He Q.Y. Fractionation of proteins by heparin chromatography. Methods. Mol. Biol. 2008, 424:213-221.
35. Muro A.F., Chauhan A.K., Gajovic S., Iaconcig A., Porro F., Baralle F.E. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J. Cell Biol. 2003, 162:149-160.
36. ffrench-Constant C. Alternative splicing of fibronectin-many different proteins but few different functions. Exp. Cell Res. 1995, 221:261-271.
37. Kornblihtt A.R., Pesce C.G., Alonso C.R., Cramer P., Srebrow A., Werbajh S., Muro A.F. The fibronectin gene as a model for splicing and transcription studies. FASEB J. 1996, 10:248-257.
38. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigueş S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., Marra M.A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences,. Proc. Natl. Acad. Sci. USA 2002, 99:16899-16903.
39. Scarpa S., Belardelli F., Musiani P., Modesti A. Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-alpha 1 gene. J. Pathol. 1997, 181:116-123.
40. Friedman R., Gelfand T., Weiss D.W., Doljanski F. Patterns of fibronectin deposition in normal and neoplastic fibroblasts and mammary tissue. Int. J. Tissue React. 1984, 6:291-301.
41. Schwarzbauer J.E., Spencer C.S., Wilson C.L. Selective secretion of alternatively spliced fibronectin variants. J. Cell Biol. 1989, 109:3445-3453.
42. Mao Y., Schwarzbauer J.E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 2005, 24:389-399.
43. Zhu B.C., Laine R.A. Polylactosamine glycosylation on human fetal placental fibronectin weakens the binding affinity of fibronectin to gelatin. J. Biol. Chem. 1985, 260:4041-4045.
44. Benedetto A., Amici C., Djaczenko W., Zaniratti S., Butto S., Elia G. Malignancy of Friend erythroleukemic cells in DBA/2 mice correlated with their level of fibronectin sensitivity. Ann. Ist. Super. Sanità 1982, 18:447-451.
45. Benedetto A., Amici C., Djaczenko W., Zaniratti S., Elia G. Acquisition of sensitivity to exogenous fibronectin by Friend leukemia cells correlates with reduction of their tumorigenic potential. Int. J. Cancer 1982, 30:663-667.
46. Sugahara H., Kanakura Y., Furitsu T., Ishihara K., Oritani K., Ikeda H., Kitayama H., Ishikawa J., Hashimoto K., Kanayama Y., Kitamura Y. Matsuzawa, Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J. Exp. Med. 1994, 179:1757-1766.
47. Cheresh D.A., Stupack D.G. Integrin-mediated death: an explanation of the integrin-knockout phenotype?. Nat. Med. 2002, 8:193-194.
48. Goltry K.L., Patel V.P. Specific domains of fibronectin mediate adhesion and migration of early murine erythroid progenitors. Blood 1997, 90:138-147.
49. Gupta Roy B., Cohen C.M. Maturation of murine erythroleukemia cells committed to differentiation requires protein kinase C. J. Biol. Chem. 1992, 267:15326-15333.
50. Ali I.U., Hynes R.O. Effects of LETS glycoprotein on cell motility. Cell 1978, 14:439-446.
51. Morla A., Zhang Z., Ruoslahti E. Superfibronectin is a functionally distinct form of fibronectin. Nature 1994, 367:193-196.
52. Okada N., Watarai M., Ozeri V., Hanski E., Caparon M., Sasakawa C. A matrix form of fibronectin mediates enhanced binding of Streptococcus pyogenes to host tissue. J. Biol. Chem. 1997, 272:26978-26984.
53. Pasqualini R., Bourdoulous S., Koivunen E., Woods V.L., Ruoslahti E. A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat. Med. 1996, 2:1197-1203.